风湿性二尖瓣修复术后轻度残余反流的预测因素与预后:基于心脏CT的双中心队列分析
本研究为双中心回顾性队列,纳入580例风湿性二尖瓣病变成功行修复术患者,按术后超声分为无MR组(371例)与残余轻度MR组(209例),用心脏CT评估瓣膜解剖与钙化。结果显示残余轻度MR与进展至中/重度MR风险升高相关,但随访期内生存无差异;术前CT有助于识别高危患者。
要点
- 风湿性二尖瓣修复术后残余轻度MR并不少见,与远期MR进展风险升高相关。
- 瓣膜钙化、瓣下融合等CT解剖特征与残余轻度MR独立相关。
- 残余轻度MR在有限随访期内未影响长期生存,术前CT可用于风险分层。
核心结论
- 二尖瓣修复术后残余轻度MR与进展至中/重度MR风险增加相关,但在有限随访期内不影响长期生存。
- 术前心脏CT可通过识别钙化与瓣下融合等解剖特征,帮助判断残余轻度MR高危患者。
研究设计与样本
- 双中心回顾性队列研究,纳入580例在中国两家高容量中心成功行二尖瓣修复的风湿性二尖瓣病变患者。
- 依据术后超声将患者分为无MR组(n=371)与残余轻度MR组(n=209),并用心脏CT评估二尖瓣解剖与钙化。
- 采用逻辑回归识别残余轻度MR相关因素,长期随访分析MR进展与生存,并用倾向性评分匹配校正混杂因素。
主要发现
- 平均年龄57.6±7.5岁,女性占73.8%。
- 残余轻度MR组二尖瓣钙化率(56.0% vs 43.9%,P=.007)与瓣下融合率(27.3% vs 19.7%,P=.045)均高于无MR组。
- 心房颤动、收缩期肺动脉压、钙化体积及乳头肌或腱索融合与残余轻度MR独立相关。
- 7年后残余轻度MR组免于进展至中/重度MR的比例更低(66.2% vs 84.9%,P=.017)。
- 两组生存率无差异(97.1% vs 96.7%,P=.98)。
关键数值与推荐
- 残余轻度MR组二尖瓣钙化56.0% vs 无MR组43.9%(P=.007)。
- 残余轻度MR组瓣下融合27.3% vs 无MR组19.7%(P=.045)。
- 7年免于进展至中/重度MR:残余轻度MR组66.2% vs 无MR组84.9%(P=.017)。
- 生存率:残余轻度MR组97.1% vs 无MR组96.7%(P=.98)。
临床怎么用
- 术前心脏CT评估二尖瓣钙化体积与瓣下融合,可辅助识别修复术后残余轻度MR高危患者。
- 对存在钙化或瓣下融合等解剖风险的患者,术后应加强超声随访以监测MR进展。
- 残余轻度MR患者虽生存未受影响,但仍需关注其中/重度MR进展风险。
局限性
- 本研究为回顾性队列设计,随访时间有限,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Rheumatic mitral disease remains a significant health issue, especially in developing regions. Although mitral valve (MV) repair improves outcomes, residual mild mitral regurgitation (MR) is common. This study aims to identify clinical and anatomical factors associated with residual mild MR after MV repair and to assess its impact on MR progression and survival. METHODS: A dual-center, retrospective cohort study was undertaken of 580 patients with rheumatic mitral disease who underwent MV repair successfully at 2 high-volume centers in China. Patients were classified as having no MR (n = 371) or residual mild MR (n = 209) on the basis of postoperative echocardiography. Cardiac computed tomography was used to assess MV anatomy and calcification. Logistic regression identified factors associated with residual mild MR. Long-term follow-up analyzed MR progression and survival, with propensity score matching to adjust for confounders. RESULTS: The mean age was 57.6 ± 7.5 years, and 73.8% were female. Patients with residual mild MR exhibited greater rates of MV calcification (56.0% vs 43.9%, P = .007) and subvalvular fusion (27.3% vs 19.7%, P = .045). Atrial fibrillation, systolic pulmonary artery pressure, calcification volume, and papillary muscle or chordae tendineae fusion were independently associated with residual mild MR. After 7 years, the residual mild MR group had lower freedom from progression to moderate/severe MR (66.2% vs 84.9%, P = .017) but no difference in survival (97.1% vs 96.7%, P = .98). CONCLUSIONS: Residual mild MR after MV repair is associated with an increased risk of MR progression but does not impact long-term survival during limited follow-up. Preoperative cardiac computed tomography provides valuable guidance by identifying patients at greater risk for residual mild MR.
引用
- Liu Z, Zhang H, Wang M, et al. Predictors and prognosis of mild regurgitation after rheumatic mitral valve repair: A dual-center cohort analysis on the basis of cardiac computed tomography. J Thorac Cardiovasc Surg. 2025. PMID: 40759361. doi:10.1016/j.jtcvs.2025.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。